Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Not applicableUnknownNCT02646462
What this trial is testing

Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Michael Bau Mortensen 200
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT05161013
What this trial is testing

A Proof-of-Concept Study Evaluating LINFU™

Who this might be right for
Pancreas AdenocarcinomaDysplasia
Adenocyte, LLC 12
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Not applicableStudy completedNCT02080650
What this trial is testing

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Who this might be right for
Prostate CancerRenal Cell CarcinomaBladder Cancer+5 more
Duke University 62
Testing effectiveness (Phase 2)Looking for participantsNCT06598007
What this trial is testing

Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Ductal Adenocarcinoma
Crossignal Therapeutics, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT00499486
What this trial is testing

Sirolimus in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT03991962
What this trial is testing

Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Yale University 28
Large-scale testing (Phase 3)Active Not RecruitingNCT04793932
What this trial is testing

Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)

Who this might be right for
Pancreas Ductal Adenocarcinoma
Associazione Italiana per lo Studio del Pancreas 261
Testing effectiveness (Phase 2)WithdrawnNCT06110598
What this trial is testing

CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)

Who this might be right for
Pancreas CancerPancreas Adenocarcinoma
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT01360853
What this trial is testing

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Traws Pharma, Inc. 160
Not applicableUnknownNCT05095064
What this trial is testing

Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
University Hospital, Antwerp 60
Testing effectiveness (Phase 2)Study completedNCT01553019
What this trial is testing

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Florida 2
Testing effectiveness (Phase 2)Ended earlyNCT02352831
What this trial is testing

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerCancer of PancreasCancer of the Pancreas+1 more
Washington University School of Medicine 16
Not applicableActive Not RecruitingNCT04472910
What this trial is testing

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma

Who this might be right for
Resectable Pancreatic Cancer
University Health Network, Toronto 84
Testing effectiveness (Phase 2)Looking for participantsNCT04421820
What this trial is testing

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Who this might be right for
Colorectal CancerPancreatic CancerGastric Cancers+1 more
Bold Therapeutics, Inc. 220
Testing effectiveness (Phase 2)Study completedNCT04705818
What this trial is testing

Combining Epigenetic And Immune Therapy to Beat Cancer.

Who this might be right for
Advanced Solid TumorAdvanced Colorectal CarcinomaAdvanced Soft-tissue Sarcoma+2 more
Institut Bergonié 164
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Next Page